查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
拋棄式生物反應器市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按產品、類型、細胞類型、分子、按應用、用途、最終用戶、地區和競賽
市場調查報告書
商品編碼
1326512

拋棄式生物反應器市場 - 2018-2028 年全球行業規模、佔有率、趨勢、機會和預測，按產品、類型、細胞類型、分子、按應用、用途、最終用戶、地區和競賽

Single-Use Bioreactors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Type, By Type of Cell, By Molecule, By Application, By Usage, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 116 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

預計全球拋棄式生物反應器市場在 2024-2028 年預測期內年複合成長率將穩定成長。這可以歸因於研發（R＆D）活動、合作和戰略夥伴關係的不斷增加，以及對新疫苗、治療方法和慢性病和傳染病的不斷增加的需求的飆升。此外，單克隆抗體的不斷發展預計將創造對用於生產設施的 SUB 的需求，從而推動細分市場的成長。 2022 年1 月，HaemaLogiX Ltd (HaemaLogiX) 和Lonza 達成協議，生產HaemaLogiX 的領先多發性骨髓瘤候選藥物和KappaMab 的下一個臨床批次(cGMP)，KappaMab 是一種單克隆抗體，與細胞表面靶標結合，稱為kappa 骨髓瘤抗原 (KMA) 存在於骨髓瘤癌細胞上，而非正常漿細胞上。

對生物製藥的需求不斷增加

生物製藥在推動全球拋棄式生物反應器市場的成長方面發揮著重要作用。生物製藥是利用細菌、酵母或哺乳動物細胞等活生物體生產的藥物和疫苗。拋棄式生物反應器因其成本效益、效率和靈活性而被廣泛用於這些生物製藥的生產。對生物製藥的需求不斷成長是拋棄式生物反應器市場的主要驅動力之一。生物製藥已成為現代醫學的重要組成部分，為各種疾病提供針對性和個性化的治療。在人口老齡化、慢性病患病率上升以及對創新和標靶治療的需求等因素的推動下，全球生物製藥市場預計將以顯著的速度成長。與傳統不銹鋼生物反應器相比，拋棄式生物反應器具有多種優勢，例如較低的資本和營運成本、降低的交叉污染風險以及更大的靈活性。這些優點使拋棄式生物反應器成為生產生物製藥的有吸引力的選擇，特別是對於小批量和臨床試驗。生物製藥行業正在採用新的生物加工技術，例如高密度細胞培養和連續製造，這需要靈活高效的生物反應器。拋棄式生物反應器可以適應不斷變化的工藝要求，使其成為這些新技術的理想選擇。

拋棄式生物反應器的成本效益和效率

成本效益和效率是推動全球拋棄式生物反應器市場成長的關鍵因素。拋棄式生物反應器在成本和效率方面比傳統不銹鋼生物反應器具有多種優勢。拋棄式生物反應器的主要優點之一是其較低的資本成本。傳統的不銹鋼生物反應器需要在基礎設施和設備方面進行大量的前期資本投資，而拋棄式生物反應器需要的資本投資要少得多。這使得拋棄式生物反應器成為中小型公司以及用於降低資本成本的研發目的的有吸引力的選擇；與傳統生物反應器相比，拋棄式生物反應器的營運成本更低。使用拋棄式組件（例如袋子、過濾器和感測器）可以減少清潔和消毒的需要，而清潔和消毒可能既耗時又昂貴。這降低了批次之間交叉污染的風險，確保更高的品質和更一致的產品。拋棄式生物反應器提供更大的靈活性，從而提高效率。它們可以快速、輕鬆地設置，從而縮短產品周轉時間。拋棄式生物反應器更能適應工藝要求的變化，使其成為研究和開發以及小規模生產的理想選擇。

日益關注個性化醫療

個性化醫療是全球拋棄式生物反應器市場成長的主要驅動力。個性化醫療是一種醫療保健方法，在為患者設計治療計劃時考慮基因、環境和生活方式的個體差異。這種方法需要生產有針對性的個體化療法，這可以使用生物製藥和拋棄式生物反應器來實現。使用拋棄式生物反應器可以更高效、更具成本效益地生產生物藥品，這是個性化醫療的基礎。與傳統不銹鋼生物反應器相比，拋棄式生物反應器在靈活性、效率和可擴展性方面具有多種優勢，使其成為生產靶向和個性化療法的理想選擇。

生物加工技術的進步

技術和研究的進步是全球拋棄式生物反應器市場成長的關鍵驅動力。隨著生物製藥行業的不斷發展和擴張，對更高效、更具成本效益的生物加工解決方案的需求日益成長。新材料和製造程序的發展催生了更先進的拋棄式生物反應器的生產，這些生物反應器具有更高水平的性能、可靠性和可擴展性。例如，聚乙烯和聚丙烯等先進聚合物的使用導致了拋棄式生物反應器的生產，這些生物反應器更耐用，能耐受更廣泛的化學品和溫度範圍。此外，自動化和過程控制的進步導致生物加工操作更加精確和高效，進一步推動了對拋棄式生物反應器的需求。自動化技術有助於降低污染風險，最大限度地減少操作員錯誤，並提高生物加工操作的速度和準確性。更複雜的感測器和分析工具的發展使得可以對生物過程進行更詳細的監測和控制。這提高了工藝效率、提高了產品產量並降低了成本。隨著研究不斷發現生物製藥的新應用和用途，對更先進的拋棄式生物反應器的需求預計將會成長。這些進步將繼續推動全球拋棄式生物反應器市場的創新和成長，提供更高效、更具成本效益的生物加工解決方案，以滿足生物製藥行業的需求。

生物製藥行業的資金不斷增加

不斷成長的政府支持對全球拋棄式生物反應器市場的成長產生重大影響。世界各國政府越來越認知到生物製藥行業的重要性以及這些生物加工技術的作用，例如拋棄式生物反應器，在新藥等生物製藥產品的開發和生產中發揮著重要作用。各國政府以多種方式為拋棄式生物反應器市場的成長提供支持，包括研發資金、稅收優惠和監管支持，這將在預測期內進一步推動市場的成長。例如，在美國，美國國立衛生研究院 (NIH) 和生物醫學高級研究與發展局 (BARDA) 為新型生物加工技術（包括拋棄式生物反應器）的研發提供資金。政府在監管生物製藥產品的安全性和有效性方面發揮著至關重要的作用，用於生產這些產品的技術將加速其在生物製藥製造中的採用，並推動市場多年來的成長。

近期發展

  • 2022 年 3 月，Sartorius AG 宣布推出新型拋棄式生物反應器系統 BIOSTAT STR (R) 1000。該系統旨在滿足大規模生物加工不斷成長的需求，並提供先進的自動化和控制功能。
  • 2022 年 1 月，GE Healthcare Life Sciences 宣布收購創新生物加工解決方案提供商 Univercells Technologies。此次收購預計將擴大 GE Healthcare 在拋棄式生物反應器市場的產品範圍，並增強其在生物製藥行業的地位。
  • 2021 年 12 月，賽默飛世爾科技宣布推出新型拋棄式生物反應器 HyPerforma (TM) 拋棄式生物反應器 (SUB)。該系統旨在提供高產量和工藝效率，並提高靈活性和可擴展性。
  • 2021 年 11 月，默克公司宣布擴建其在美國的拋棄式製造工廠。此次擴建預計將提高默克生產拋棄式生物反應器的能力，並支持對生物製藥產品不斷成長的需求。
  • 2021 年 9 月，頗爾公司宣布推出新型拋棄式生物反應器 Allegro (TM) STR 400。該系統提供先進的自動化和控制功能，並提高了生物加工操作的靈活性和可擴展性。

可用的客製化：

根據給定的市場數據，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自定義選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 考慮學習的年份
    • 主要市場細分

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要行業合作夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球拋棄式生物反應器市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 副產品（拋棄式生物反應器系統、拋棄式介質袋、拋棄式過濾組件、其他產品）
    • 按類型（攪拌罐 SUB、波誘導 SUB、鼓泡塔 SUB、其他 SUB）
    • 按細胞類型（哺乳動物細胞、細菌細胞、酵母細胞、其他細胞）
    • 按分子（單克隆抗體、疫苗、基因修飾細胞、幹細胞、其他分子）
    • 按應用（研究與開發、生物生產）
    • 按用途（實驗室規模生產、中試規模生產、大規模生產）
    • 按最終用戶（製藥和生物製藥公司、CROS 和 CMOS、學術和研究機構）
    • 按地區（北美、歐洲、亞太地區、南美、中東和非洲）
    • 按公司分類 (2022)
  • 市場地圖
    • 按產品分類
    • 按類型
    • 按電池類型
    • 按分子
    • 按應用
    • 按用途
    • 按最終用戶
    • 按地區

第 6 章：北美拋棄式生物反應器市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 副產品（拋棄式生物反應器系統、拋棄式介質袋、拋棄式過濾組件、其他產品）
    • 按類型（攪拌罐 SUB、波誘導 SUB、鼓泡塔 SUB、其他 SUB）
    • 按細胞類型（哺乳動物細胞、細菌細胞、酵母細胞、其他細胞）
    • 按分子（單克隆抗體、疫苗、基因修飾細胞、幹細胞、其他分子）
    • 按應用（研究與開發、生物生產）
    • 按用途（實驗室規模生產、中試規模生產、大規模生產）
    • 按最終用戶（製藥和生物製藥公司、CROS 和 CMOS、學術和研究機構）
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲拋棄式生物反應器市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 副產品（拋棄式生物反應器系統、拋棄式介質袋、拋棄式過濾組件、其他產品）
    • 按類型（攪拌罐 SUB、波誘導 SUB、鼓泡塔 SUB、其他 SUB）
    • 按細胞類型（哺乳動物細胞、細菌細胞、酵母細胞、其他細胞）
    • 按分子（單克隆抗體、疫苗、基因修飾細胞、幹細胞、其他分子）
    • 按應用（研究與開發、生物生產）
    • 按用途（實驗室規模生產、中試規模生產、大規模生產）
    • 按最終用戶（製藥和生物製藥公司、CROS 和 CMOS、學術和研究機構）
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區拋棄式生物反應器市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 副產品（拋棄式生物反應器系統、拋棄式介質袋、拋棄式過濾組件、其他產品）
    • 按類型（攪拌罐 SUB、波誘導 SUB、鼓泡塔 SUB、其他 SUB）
    • 按細胞類型（哺乳動物細胞、細菌細胞、酵母細胞、其他細胞）
    • 按分子（單克隆抗體、疫苗、基因修飾細胞、幹細胞、其他分子）
    • 按應用（研究與開發、生物生產）
    • 按用途（實驗室規模生產、中試規模生產、大規模生產）
    • 按最終用戶（製藥和生物製藥公司、CROS 和 CMOS、學術和研究機構）
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第 9 章：南美拋棄式生物反應器市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 副產品（拋棄式生物反應器系統、拋棄式介質袋、拋棄式過濾組件、其他產品）
    • 按類型（攪拌罐 SUB、波誘導 SUB、鼓泡塔 SUB、其他 SUB）
    • 按細胞類型（哺乳動物細胞、細菌細胞、酵母細胞、其他細胞）
    • 按分子（單克隆抗體、疫苗、基因修飾細胞、幹細胞、其他分子）
    • 按應用（研究與開發、生物生產）
    • 按用途（實驗室規模生產、中試規模生產、大規模生產）
    • 按最終用戶（製藥和生物製藥公司、CROS 和 CMOS、學術和研究機構）
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲拋棄式生物反應器市場展望

  • 市場規模及預測
    • 按價值
  • 市場佔有率及預測
    • 副產品（拋棄式生物反應器系統、拋棄式介質袋、拋棄式過濾組件、其他產品）
    • 按類型（攪拌罐 SUB、波誘導 SUB、鼓泡塔 SUB、其他 SUB）
    • 按細胞類型（哺乳動物細胞、細菌細胞、酵母細胞、其他細胞）
    • 按分子（單克隆抗體、疫苗、基因修飾細胞、幹細胞、其他分子）
    • 按應用（研究與開發、生物生產）
    • 按用途（實驗室規模生產、中試規模生產、大規模生產）
    • 按最終用戶（製藥和生物製藥公司、CROS 和 CMOS、學術和研究機構）
    • 按國家/地區
  • MEA：國家分析
    • 南非拋棄式生物反應器
    • 沙烏地阿拉伯拋棄式生物反應器
    • 阿拉伯聯合大公國拋棄式生物反應器

第 11 章：市場動態

  • 司機
    • 對實驗室自動化活動的需求不斷成長
    • 生物樣本庫擴大採用實驗室資訊學
    • 擴大引入技術先進的軟體服務
  • 挑戰
    • 缺乏實驗室資訊學整合標準
    • 嚴格的規定

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球拋棄式生物反應器市場：SWOT 分析

第 14 章：波特的五力分析

  • 行業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 產品供應
  • 最近的發展
  • 財務（據報導）
  • 主要人員
  • SWOT分析
    • ABEC,INC.
    • Able Corporation & Biott Corporation.
    • BBI-Biotech Gmbh.
    • Cellexus Biosystems PLC.
    • Celltainer Biotech BV.
    • Danaher Corp.
    • Distek Inc.
    • Eppendorf AG.
    • G&G Technologies, Inc.
    • Getinge AB.

第 16 章：戰略建議

簡介目錄
Product Code: 15169

Global Single-Use Bioreactors Market is anticipated to witness a growth of steady CAGR in the forecast period, 2024-2028. This can be ascribed to the increasing research and development (R&D) activities, collaborations, and strategic partnerships, along with soaring demand for new vaccines, therapeutics, and rising chronic and infectious diseases. Also, the growing development of monoclonal antibodies is anticipated to create demand for SUBs used for manufacturing facilities, thereby expected to drive segment growth. In January 2022, HaemaLogiX Ltd (HaemaLogiX) and Lonza entered into an agreement for manufacturing the next clinical batch (cGMP) of HaemaLogiX's lead multiple myeloma drug candidate and KappaMab, which is a monoclonal antibody and binds to a cell surface target which is called as kappa myeloma antigen (KMA) and found on myeloma cancer cells and not on normal plasma cells.

Increasing demand for biopharmaceuticals

Biopharmaceuticals play a significant role in driving the growth of the Global Single-Use Bioreactors Market. Biopharmaceuticals are drugs and vaccines that are produced using living organisms such as bacteria, yeast, or mammalian cells. Single-use bioreactors are widely used in the production of these biopharmaceuticals due to their cost-effectiveness, efficiency, and flexibility. The increasing demand for biopharmaceuticals is one of the key drivers of the Single-Use Bioreactors Market. Biopharmaceuticals have become an important component of modern medicine, as they offer targeted and personalized treatments for various diseases. The Global Biopharmaceuticals Market is expected to grow at a significant rate, driven by factors such as an aging population, increasing prevalence of chronic diseases, and the need for innovative and targeted therapies. Single-use bioreactors offer several advantages over traditional stainless-steel bioreactors, such as lower capital and operational costs, reduced risk of cross-contamination, and greater flexibility. These advantages make single-use bioreactors an attractive option to produce biopharmaceuticals, particularly for smaller batches and clinical trials. The biopharmaceutical industry is adopting new bioprocessing technologies, such as high-density cell cultures and continuous manufacturing, which require flexible and efficient bioreactors. Single-use bioreactors can adapt to changing process requirements, making them ideal for these new technologies.

Cost-effectiveness and efficiency of single-use bioreactors

Cost-effectiveness and efficiency are key factors driving the growth of the Global Single-Use Bioreactors Market. Single-use bioreactors offer several advantages over traditional stainless-steel bioreactors in terms of cost and efficiency. One of the primary advantages of single-use bioreactors is their lower capital cost. Traditional stainless-steel bioreactors require significant upfront capital investments in infrastructure and equipment, whereas single-use bioreactors require much less capital investment. This makes single-use bioreactors an attractive option for small and medium-sized companies, as well as for research and development purposes to lower capital costs; single-use bioreactors offer lower operational costs compared to traditional bioreactors. The use of single-use components, such as bags, filters, and sensors, reduces the need for cleaning and sterilization, which can be time-consuming and costly. This reduces the risk of cross-contamination between batches, ensuring higher quality and more consistent products. Single-use bioreactors offer greater flexibility, which can lead to increased efficiency. They can be quickly and easily set up, allowing for faster product turnaround times. Single-use bioreactors are more adaptable to changes in process requirements, making them ideal for research and development, as well as for small-scale production.

Growing focus on personalized medicine

Personalized medicine is a major driver of the growth of the Global Single-Use Bioreactors Market. Personalized medicine is an approach to healthcare that considers individual variability in genes, environment, and lifestyle when designing treatment plans for patients. This approach requires the production of targeted and individualized therapies, which can be achieved using biopharmaceuticals and single-use bioreactors. The use of single-use bioreactors allows for more efficient and cost-effective production of biopharmaceuticals, which are the foundation of personalized medicine. Single-use bioreactors offer several advantages over traditional stainless-steel bioreactors in terms of flexibility, efficiency, and scalability, making them ideal for producing targeted and personalized therapies.

Single-use bioreactors are particularly well-suited to produce smaller batches of biopharmaceuticals, which are often required for personalized medicine. They are ideal for research and development purposes, as they allow for rapid and cost-effective testing of new therapies. The demand for personalized medicine is expected to grow in the coming years, driven by factors such as an aging population, increasing prevalence of chronic diseases, and advances in genomics and proteomics. This growth is expected to fuel the demand for biopharmaceuticals and single-use bioreactors, as personalized medicine requires the production of targeted and individualized therapies.

Advancements in bioprocessing technology

Advancements in technology and research are key drivers of the growth of the Global Single-Use Bioreactors Market. As the biopharmaceutical industry continues to evolve and expand, there is a growing need for more efficient and cost-effective bioprocessing solutions. The development of new materials and manufacturing processes has led to the production of more advanced single-use bioreactors that offer higher levels of performance, reliability, and scalability. For example, the use of advanced polymers such as polyethylene and polypropylene has led to the production of single-use bioreactors that are more durable and resistant to a wider range of chemicals and temperature ranges. In addition, advancements in automation and process control have led to more precise and efficient bioprocessing operations, further driving the demand for single-use bioreactors. Automation technology can help to reduce the risk of contamination, minimize operator error, and increase the speed and accuracy of bioprocessing operations. The development of more sophisticated sensors and analytical tools has allowed for more detailed monitoring and control of bioprocesses. This has led to improved process efficiency, higher product yields, and reduced costs. As research continues to uncover new applications and uses for biopharmaceuticals, the demand for more advanced single-use bioreactors is expected to grow. These advancements will continue to drive innovation and growth in the Global Single-Use Bioreactors Market, providing more efficient and cost-effective bioprocessing solutions to meet the needs of the biopharmaceutical industry.

Growing funding for the biopharmaceutical industry

Growing government support plays a significant impact in the growth of the Global Single-Use Bioreactors Market. Governments around the world are increasingly recognizing the importance of the biopharmaceutical industry and the role of these bioprocessing technologies, such as single-use bioreactors, play an important role in the development and production of biopharmaceutical products such as novel drugs. Governments provide support for the growth of the single-use bioreactors market in several ways, including funding for research and development, tax incentives, and regulatory support which will further drive the growth of the market during the forecast period. For example, in the United States, the National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA) provide funding for research and development of new bioprocessing technologies, including single-use bioreactors. Governments play a crucial role in regulating the safety and efficacy of biopharmaceutical products, and the technologies used to produce them will accelerate their adoption in biopharmaceutical manufacturing and propel the growth of the market over the years.

Recent Development

  • In March 2022, Sartorius AG announced the launch of its new single-use bioreactor system, BIOSTAT STR® 1000. The system was designed to meet the growing demand for large-scale bioprocessing and offers advanced automation and control features.
  • In January 2022, GE Healthcare Life Sciences announced the acquisition of Univercells Technologies, a provider of innovative bioprocessing solutions. The acquisition is expected to expand GE Healthcare's offerings in the single-use bioreactors market and enhance its position in the biopharmaceutical industry.
  • In December 2021, Thermo Fisher Scientific announced the launch of its new single-use bioreactor, the HyPerforma™ Single-Use Bioreactor (SUB). The system is designed to provide high yields and process efficiencies with improved flexibility and scalability.
  • In November 2021, Merck KGaA announced the expansion of its single-use manufacturing facility in the United States. The expansion is expected to increase Merck's capacity to produce single-use bioreactors and support the growing demand for biopharmaceutical products.
  • In September 2021, Pall Corporation announced the launch of its new single-use bioreactor, the Allegro™ STR 400. The system offers advanced automation and control features, as well as improved flexibility and scalability for bioprocessing operations.

Market Segmentation

Global Single-Use Bioreactors market can be segmented by product, type, type of cell, molecule, application, usage, end user, and by region. Based on product, the market can be segmented into Single-use bioreactor systems, Single-use media bags, Single-use filtration assemblies, and other products. Based on type, the market can be segmented into Stirred tank SUB, Wave induced SUB, Bubble Column SUB, and Other SUB. Based on the type of cell, the market can be differentiated into Mammalian Cell, Bacterial Cell, Yeast Cell, and Other Cells. Based on molecules, the market can be grouped into Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, and Other molecules. Based on application, the market can be segmented into Research and Development, Bioproduction. Based on usage, the market can be differentiated into Lab scale production, Pilot scale production, and large scale production. Based on end users, the market can be grouped into Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, and Academic and Research Institutes.

Market Players

ABEC, INC., Able Corporation & Biott Corporation., BBI-Biotech Gmbh., Cellexus Biosystems PLC., Celltainer Biotech BV., Danaher Corp., Distek Inc., Eppendorf AG., G&G Technologies, Inc., Getinge AB are some of the leading players operating in the Global Single-Use Bioreactors Market.

Report Scope:

In this report, the Global Single-Use Bioreactors market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Single-Use Bioreactors Market, By Product:

  • Single-use bioreactor systems
  • Single use media bags
  • Single use filtration assemblies
  • other products

Single-Use Bioreactors Market, By Type:

  • Stirred tank SUB.
  • Wave-induced SUB.
  • Bubble Column SUB
  • Other SUB

Single-Use Bioreactors Market, By Type of Cell:

  • Mammalian Cell
  • Bacterial Cell
  • Yeast Cell
  • Other Cells

Single-Use Bioreactors Market, By Molecule:

  • Monoclonal Antibodies
  • Vaccines
  • Gene Modified Cells
  • Stem Cells
  • Other molecules

Single-Use Bioreactors Market, By Application:

  • Research and Development
  • Bioproduction

Single-Use Bioreactors Market, By Usage:

  • Lab-scale production
  • Pilot-scale production
  • large scale production

Single-Use Bioreactors Market, By End User:

  • Pharmaceutical and Biopharmaceutical companies
  • CROSs & CMOS
  • Academic and Research Institutes

Single-Use Bioreactors Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Single-Use Bioreactors Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Single-Use Bioreactors Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 5.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 5.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 5.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 5.2.5. By Application (Research and Development, Bioproduction)
    • 5.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 5.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 5.2.8. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.9. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Product
    • 5.3.2 By Type
    • 5.3.3 By Type of Cell
    • 5.3.4 By Molecule
    • 5.3.5 By Application
    • 5.3.6 By Usage
    • 5.3.7 By End User
    • 5.3.5 By Region

6. North America Single-Use Bioreactors Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 6.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 6.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 6.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 6.2.5. By Application (Research and Development, Bioproduction)
    • 6.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 6.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 6.2.8. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Single-Use Bioreactors Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Type of Cell
        • 6.3.1.2.4. By Molecule
        • 6.3.1.2.5. By Application
        • 6.3.1.2.6. By Usage
        • 6.3.1.2.7. By End User
    • 6.3.2. Canada Single-Use Bioreactors Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Type of Cell
        • 6.3.2.2.4. By Molecule
        • 6.3.2.2.5. By Application
        • 6.3.2.2.6. By Usage
        • 6.3.2.2.7. By End User
    • 6.3.3. Mexico Single-Use Bioreactors Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Type of Cell
        • 6.3.3.2.4. By Molecule
        • 6.3.3.2.5. By Application
        • 6.3.3.2.6. By Usage
        • 6.3.3.2.7. By End User

7. Europe Single-Use Bioreactors Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 7.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 7.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 7.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 7.2.5. By Application (Research and Development, Bioproduction)
    • 7.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 7.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 7.2.8. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Single-Use Bioreactors Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Type of Cell
        • 7.3.1.2.4. By Molecule
        • 7.3.1.2.5. By Application
        • 7.3.1.2.6. By Usage
        • 7.3.1.2.7. By End User
    • 7.3.2. Germany Single-Use Bioreactors Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Type of Cell
        • 7.3.2.2.4. By Molecule
        • 7.3.2.2.5. By Application
        • 7.3.2.2.6. By Usage
        • 7.3.2.2.7. By End User
    • 7.3.3. United Kingdom Single-Use Bioreactors Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Type of Cell
        • 7.3.3.2.4. By Molecule
        • 7.3.3.2.5. By Application
        • 7.3.3.2.6. By Usage
        • 7.3.3.2.7. By End User
    • 7.3.4. Italy Single-Use Bioreactors Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Type of Cell
        • 7.3.4.2.4. By Molecule
        • 7.3.4.2.5. By Application
        • 7.3.4.2.6. By Usage
        • 7.3.4.2.7. By End User
    • 7.3.5. Spain Single-Use Bioreactors Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Type of Cell
        • 7.3.5.2.4. By Molecule
        • 7.3.5.2.5. By Application
        • 7.3.5.2.6. By Usage
        • 7.3.5.2.7. By End User

8. Asia-Pacific Single-Use Bioreactors Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 8.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 8.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 8.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 8.2.5. By Application (Research and Development, Bioproduction)
    • 8.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 8.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 8.2.8. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Single-Use Bioreactors Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Type of Cell
        • 8.3.1.2.4. By Molecule
        • 8.3.1.2.5. By Application
        • 8.3.1.2.6. By Usage
        • 8.3.1.2.7. By End User
    • 8.3.2. India Single-Use Bioreactors Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Type of Cell
        • 8.3.2.2.4. By Molecule
        • 8.3.2.2.5. By Application
        • 8.3.2.2.6. By Usage
        • 8.3.2.2.7. By End User
    • 8.3.3. Japan Single-Use Bioreactors Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Type of Cell
        • 8.3.3.2.4. By Molecule
        • 8.3.3.2.5. By Application
        • 8.3.3.2.6. By Usage
        • 8.3.3.2.7. By End User
    • 8.3.4. South Korea Single-Use Bioreactors Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Type of Cell
        • 8.3.4.2.4. By Molecule
        • 8.3.4.2.5. By Application
        • 8.3.4.2.6. By Usage
        • 8.3.4.2.7. By End User
    • 8.3.5. Australia Single-Use Bioreactors Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Type of Cell
        • 8.3.5.2.4. By Molecule
        • 8.3.5.2.5. By Application
        • 8.3.5.2.6. By Usage
        • 8.3.5.2.7. By End User

9. South America Single-Use Bioreactors Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 9.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 9.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 9.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 9.2.5. By Application (Research and Development, Bioproduction)
    • 9.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 9.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 9.2.8. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Single-Use Bioreactors Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Type of Cell
        • 9.3.1.2.4. By Molecule
        • 9.3.1.2.5. By Application
        • 9.3.1.2.6. By Usage
        • 9.3.1.2.7. By End User
    • 9.3.2. Argentina Single-Use Bioreactors Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Type of Cell
        • 9.3.2.2.4. By Molecule
        • 9.3.2.2.5. By Application
        • 9.3.2.2.6. By Usage
        • 9.3.2.2.7. By End User
    • 9.3.3. Colombia Single-Use Bioreactors Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Type of Cell
        • 9.3.3.2.4. By Molecule
        • 9.3.3.2.5. By Application
        • 9.3.3.2.6. By Usage
        • 9.3.3.2.7. By End User

10. Middle East and Africa Single-Use Bioreactors Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
    • 10.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
    • 10.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
    • 10.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
    • 10.2.5. By Application (Research and Development, Bioproduction)
    • 10.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
    • 10.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
    • 10.2.8. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Single-Use Bioreactors Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Type of Cell
        • 10.3.1.2.4. By Molecule
        • 10.3.1.2.5. By Application
        • 10.3.1.2.6. By Usage
        • 10.3.1.2.7. By End User
    • 10.3.2. Saudi Arabia Single-Use Bioreactors Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Type of Cell
        • 10.3.2.2.4. By Molecule
        • 10.3.2.2.5. By Application
        • 10.3.2.2.6. By Usage
        • 10.3.2.2.7. By End User
    • 10.3.3. UAE Single-Use Bioreactors Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Type of Cell
        • 10.3.3.2.4. By Molecule
        • 10.3.3.2.5. By Application
        • 10.3.3.2.6. By Usage
        • 10.3.3.2.7. By End User

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1 Growing demand for lab automation activities
    • 11.1.2 Growing adoption of lab informatics by biobanks
    • 11.1.3 Growing introduction of technologically advanced software services
  • 11.2. Challenges
    • 11.2.1 Lack of integration standards for laboratory informatics
    • 11.2.2 Stringent Regulations

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Single-Use Bioreactors Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 ABEC,INC.
    • 15.6.2 Able Corporation & Biott Corporation.
    • 15.6.3 BBI-Biotech Gmbh.
    • 15.6.4 Cellexus Biosystems PLC.
    • 15.6.5 Celltainer Biotech BV.
    • 15.6.6 Danaher Corp.
    • 15.6.7 Distek Inc.
    • 15.6.8 Eppendorf AG.
    • 15.6.9 G&G Technologies, Inc.
    • 15.6.10 Getinge AB.

16. Strategic Recommendations